Short Interest in CSL Limited (OTCMKTS:CSLLY) Declines By 98.5%

CSL Limited (OTCMKTS:CSLLY) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 300 shares, a drop of 98.5% from the February 28th total of 20,000 shares. Based on an average daily trading volume, of 134,500 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are sold short.

CSL Stock Performance

CSLLY stock traded up $0.20 during mid-day trading on Friday, hitting $79.37. The stock had a trading volume of 76,615 shares, compared to its average volume of 87,807. The firm has a fifty day simple moving average of $82.45 and a 200 day simple moving average of $89.76. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.18 and a quick ratio of 0.97. CSL has a 52 week low of $77.37 and a 52 week high of $109.00.

Analyst Ratings Changes

Separately, The Goldman Sachs Group upgraded shares of CSL to a “strong-buy” rating in a research report on Thursday, January 16th.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.